# A Healthy Volunteer Study to Establish the Bioequivalence of BG00012 Supplied by 2 Different Commercial Manufacturers

> **NCT02171208** · PHASE1 · COMPLETED · sponsor: **Biogen** · enrollment: 80 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** dimethyl fumarate - Reference form
- **DRUG:** dimethyl fumarate - Test form

## Key facts

- **NCT ID:** NCT02171208
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2015-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02171208

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02171208, "A Healthy Volunteer Study to Establish the Bioequivalence of BG00012 Supplied by 2 Different Commercial Manufacturers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02171208. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*